Lopez ES - Search Results

1

Alpha-1-antitrypsin ameliorates inflammation and neurodegeneration in the diabetic mouse retina.

Ortiz G, Lopez ES, Salica JP, Potilinski C, Fernández Acquier M, Chuluyan E, Gallo JE. Ortiz G, et al. Among authors: lopez es. Exp Eye Res. 2018 Sep;174:29-39. doi: 10.1016/j.exer.2018.05.013. Epub 2018 May 18. Exp Eye Res. 2018. PMID: 29778740

2

Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy.

Potilinski MC, Ortíz GA, Salica JP, López ES, Fernández Acquier M, Chuluyan E, Gallo JE. Potilinski MC, et al. Among authors: lopez es. PLoS One. 2020 Feb 7;15(2):e0228895. doi: 10.1371/journal.pone.0228895. eCollection 2020. PLoS One. 2020. PMID: 32032388 Free PMC article.

3

Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P₂X₂.

Lopez ES, Ortiz GA, Potilinski C, Croxatto JO, Gallo JE. Lopez ES, et al. Curr Eye Res. 2018 Apr;43(4):466-473. doi: 10.1080/02713683.2017.1416146. Epub 2017 Dec 21. Curr Eye Res. 2018. PMID: 29265937

4

Possible neuroprotective role of P2X2 in the retina of diabetic rats.

Mancini JE, Ortiz G, Potilinstki C, Salica JP, Lopez ES, Croxatto JO, Gallo JE. Mancini JE, et al. Among authors: lopez es. Diabetol Metab Syndr. 2018 Apr 12;10:31. doi: 10.1186/s13098-018-0332-7. eCollection 2018. Diabetol Metab Syndr. 2018. PMID: 29682007 Free PMC article.

5

Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization.

Lopez ES, Rizzo MM, Croxatto JO, Mazzolini G, Gallo JE. Lopez ES, et al. Cancer Chemother Pharmacol. 2011 Mar;67(3):723-8. doi: 10.1007/s00280-010-1457-z. Epub 2010 Sep 21. Cancer Chemother Pharmacol. 2011. PMID: 20857116

6

Evaluation of the Performance of an Ophthalmic Thermosensitive Hydrogel Containing Combination of Suramin and Bevacizumab.

Quinteros DA, Lopez ES, Couto JL, Maletto BA, Allemandi DA, Palma SD, Gallo JE. Quinteros DA, et al. Among authors: lopez es. Curr Pharm Des. 2016;22(43):6587-6594. doi: 10.2174/1381612822666160811160832. Curr Pharm Des. 2016. PMID: 27526793

7

[Dyspnea and petechiae after bilateral fractures of tibia].

López E, Turjanski A, Chiesa D, Rolleri Chaher MF, di Fonzo H. López E, et al. Medicina (B Aires). 2013;73(1):51. Medicina (B Aires). 2013. PMID: 23335708 Free article. Spanish. No abstract available.

8

Mi Argentina/Mi Salud: The Argentinian Citizen Digital Health Portal.

Rizzato Lede DA, Pedernera FA, López E, Speranza CD, Maid JJ, Gassino F, Argibay O, Castiglione R, Pujadas G, Gonzalez Alvaredo E, Álvarez R, Markiewicz MB, Alegre F, Ferrareis L, Rolandi F, Ayala F, Abadie DA, Cejas CA, López Osornio A, Rubinstein A. Rizzato Lede DA, et al. Stud Health Technol Inform. 2020 Jun 16;270:1011-1015. doi: 10.3233/SHTI200314. Stud Health Technol Inform. 2020. PMID: 32570534

9

[Splenic infarction. Ergotism induced by ritonavir?].

Dal Verme A, López E, Grinspon S, Fernández Pardal R, Mengia M, Mazzocchi O. Dal Verme A, et al. Medicina (B Aires). 2012;72(6):475-7. Medicina (B Aires). 2012. PMID: 23241290 Free article. Spanish.

10

Argentinian Digital Health Strategy.

Rizzato Lede DA, Pedernera FA, López E, Speranza CD, Guevel C, Maid JJ, Mac Culloch P, Rolandi F, Ayala F, Abadie DA, Baqué MI, Gassino F, Campos F, Kaminker D, Cejas CA, López Osornio A, Rubinstein A. Rizzato Lede DA, et al. Stud Health Technol Inform. 2020 Jun 16;270:818-822. doi: 10.3233/SHTI200275. Stud Health Technol Inform. 2020. PMID: 32570496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters